Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Advances in Therapy|October 28, 2020
The Association Between Switching from Synthroid<sup>®</sup> and Clinical Outcomes: US Evidence from a Retrospective Database AnalysisJames V Hennessey, Ramon Espaillat, Yinghui Duan, et al.Advances in Therapy|December 14, 2021
Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospective Study Among Patients with Hypothyroidism in a Managed Care SettingLiya Wang, Yaozhu J Chen, Michael Grabner, et al.Journal of the American Academy of Dermatology|August 29, 2024
A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvementMark Lebwohl, Michael Bukhalo, Linda Stein Gold, et al.Dermatology and Therapy|October 2, 2024
A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe PsoriasisAndrew F Alexis, Melinda Gooderham, Shawn G Kwatra, et al.Journal of the American Academy of Dermatology|August 8, 2023
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-upKim A Papp, Andrew Blauvelt, Lluís Puig, et al.Dermatology and Therapy|May 17, 2026
Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful TrialNina Magnolo, Jennifer Soung, John Frew, et al.Pageof 2